ELN — Elanix Biotechnologies AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Elanix Biotechnologies AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2014 December 31st	2015 December 31st	R2016 December 31st	2017 December 31st	2018 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	GAS	IFRS	—	—	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.034	0.073	0.074	0.212	0.02
Net Total Accounts Receivable
Net Total Receivables	—	0.086	0.071	0.914	0.634
Total Inventory
Total Other Current Assets
Total Current Assets	0.034	0.159	0.178	1.26	0.654
Net Property, Plant And Equipment	—	0.001	0.015	0.04	0.03
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.314	22.7	21.8	22.4	1.08
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.036	0.711	1.01	1.66	2.31
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	0.051	6.67	6.37	6.39	2.48
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	0.263	16.1	15.4	16	-1.4
Total Liabilities & Shareholders' Equity	0.314	22.7	21.8	22.4	1.08
Total Common Shares Outstanding